Echo Health Ventures

By Dave Muoio 09:47 am June 13, 2019
Genome Medical — a company that offers patient-facing virtual visits and provider-facing consultations with genetic experts — has raised $23 million in Series B funding. The round brings Genome Medical to $46 million in total funding. The round was led by Echo Health Ventures, with participation from LRVHealth, Casdin Capital, Perceptive Advisors, Manatt Venture Fund and Dreamers Fund, as well as...
By Laura Lovett 04:17 pm March 15, 2019
When it comes to digital health, investors get a bird’s eye view and play a major role in steering the direction of the industry’s future. That is why many are stressing the importance of a diverse viewpoint for investors in an industry focused on bringing digital tools to the masses.  Traditionally this has been a challenge for the venture space, where women only account for 12.2 percent of...
By Jonah Comstock 08:09 am April 11, 2018
Digital chronic disease management company Livongo has raised $105 million in new Series E funding, mostly from existing investors. The company also announced a partnership with nonprofit health insurance company Cambia Health Solutions. General Catalyst and Swedish investment company Kinnevik led the round, with additional participation from existing investors DFJ, Kleiner Perkins Caufield...
By Jeff Lagasse 02:55 pm July 25, 2017
Circulation is looking to change the way non-emergency patients are delivered to the hospital, and those efforts were bolstered Tuesday by the news that it raised $10.5 million in Series A financing from a group of leaders across the healthcare system.   Flare Capital Partners and The Providence Service Corporation co-led the investment and were joined by Boston Children’s Hospital, Echo Health...
By Jonah Comstock 04:51 pm November 15, 2016
Cambia Health Solutions and Mosaic Health Solutions have combined their respective investment groups into one new investor called Echo Health Ventures. Under the leadership of CEO Rob Coppedge, who has led Cambia’s investment division for the past six years, the new company will manage both companies’ existing portfolios as well as pursue new stage-agnostic investments in healthcare innovation. “...